Search Results 71-80 of 16055 for pharmacogenetics
New pharmacogenetics program offers local hospital differentiation. Karl E. Bushman, M.D., knows that pharmacogenomics can make a difference. Through Mayo ...
Read frequently asked questions and answers about genetic testing and genetic testing results from the Mayo Clinic Center for Individualized Medicine.
The complex genetic basis of common human diseases and traits necessitates the development of new statistical methods to address new questions and new data ...
The Center for Individualized Medicine aligns its programs across four pillars: Functional Omics, Digital Omics, Population Omics and Rare Disease Omics.
Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. ... Pharmacogenetic workup of ...
... pharmacogenetic testing. Transplant infectious diseases. Dr. Cummins partners with other researchers at Mayo Clinic to improve the diagnosis and treatment ...
About this study. The purpose of this study is to create a larger database and bio-repository to examine pharmacogenomics in patients with BD type I and ...
Predicting response to glucocorticoid treatment represents an unmet need. Dr. Sullivan's team plans to bridge that gap by understanding the pharmacogenetic ...
Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network. Genome Med. 2015;7(1):67 ...
... 2007; U.S. Patent No. 7026163 — Sulfotransferase Sequence Variants, 2006; Member — American Medical Informatics Association, Clinical Pharmacogenetics ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.